Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells
Loading...
Contact
Check for full-text access
Issue Date
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Publisher
License
Journal
Clinical Immunology (Orlando, Fla.)
Volume
269